UC San Diego hosting Parkinsons drug study
by Dave Schwab
Published - 03/25/14 - 09:58 AM | 13124 views | 0 0 comments | 17 17 recommendations | email to a friend | print
By Dave Schwab

UC San Diego is seeking men and women ages 45 to 80 suffering from Parkinson’s Disease to participate in a research study evaluating the impact of the drug Azilect’s potential for improving cognitive impairment caused by the condition.

Sponsored by Teva Pharmaceuticals, the clinical trial will not only further the understanding of Parkinson’s disease and a potential treatment but will also provide participants with:

• Clinical trial participation at no cost

• Study-related care at a health care facility, and

• Study-related health care monitoring

The recruitment period for the drug trial will continue through March. La Jolla is one of 44 participating sites nationwide.

The UCSD Neuroscience, Movement Disorder Center’s Irene Litvan, M.D., director of its Movement Disorders Program, is seeking volunteers in the LaJolla/San Diego county area to participate in a Parkinson’s disease (PD) clinical research study evaluating the effects of the investigational use of Azilect, rasagiline tablets.

“The study is for persons who’ve had some complaints of memory difficulty and difficulty with multitasking,” said Litvan. “The study is for the use of a medication, Azilect, for the purpose of seeing whether it can improve cognitive function in this patient population.”

Nervous tremors and stiffness are classical symptoms of Parkinson’s Disease. It is hoped, through the Azilect clinical study, that research will shed light on brain function and nerve pathways and how that affects cognition and motor skills.

Litvan said subjects chosen for the Parkinson’s study will be administered either a dose of Azilect or a placebo for a month.

For more information call the national Parkinson’s Support Solutions (PSS) at 866-880-8582.
Comments-icon Post a Comment
No Comments Yet
Comments are back! Simply post the comment (it'll complain about you failing the human test) then simply click on the captcha and then click "Post Comment" again. Comments are also welcome on our Facebook page.